Skorpios Trust - Insider Trading & Ownership

Entity
Company
Location
195 Arch. Makarios III Ave., Neocleous House, Limassol, Cyprus
Summary
The estimated value of insider holdings of Skorpios Trust is at least $127M dollars as of September 23, 2024. Skorpios Trust is the 10%+ Owner of Stoke Therapeutics, Inc. and owns shares of Stoke Therapeutics, Inc. (STOK) stock worth about $125M. Skorpios Trust is the Former 10% owner of Akero Therapeutics, Inc. and owns shares of Akero Therapeutics, Inc. (AKRO) stock worth about $2.01M.
All Insider Reports
All Insider Reports

Ownership of Skorpios Trust

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
STOK Stoke Therapeutics, Inc. 10%+ Owner $125M -$69M -35.5% Sep 19, 2024
AKRO Akero Therapeutics, Inc. Former 10% owner $2.01M Dec 1, 2022

Insider Transactions Reported by Skorpios Trust:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.